Hashimoto N - Search Results

1

Prospective analysis of efficacy and safety of an individualized-midazolam-dosing protocol for sedation during prolonged bronchoscopy.

Ogawa T, Imaizumi K, Hashimoto I, Shindo Y, Imai N, Uozu S, Shimokata T, Ito S, Hashimoto N, Sato M, Kondo M, Hasegawa Y. Ogawa T, et al. Among authors: hashimoto n, hashimoto i. Respir Investig. 2014 May;52(3):153-9. doi: 10.1016/j.resinv.2013.09.003. Epub 2013 Nov 9. Respir Investig. 2014. PMID: 24853014 Clinical Trial.

2

Effect of erythromycin on matrix metalloproteinase-9 and cell migration.

Hashimoto N, Kawabe T, Hara T, Imaizumi K, Wakayama H, Saito H, Shimokata K, Hasegawa Y. Hashimoto N, et al. J Lab Clin Med. 2001 Mar;137(3):176-83. doi: 10.1067/mlc.2001.112726. J Lab Clin Med. 2001. PMID: 11241027

3

Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer.

Noguchi M, Imaizumi K, Kawabe T, Wakayama H, Horio Y, Sekido Y, Hara T, Hashimoto N, Takahashi M, Shimokata K, Hasegawa Y. Noguchi M, et al. Among authors: hashimoto n. Cancer Gene Ther. 2001 Jun;8(6):421-9. doi: 10.1038/sj.cgt.7700320. Cancer Gene Ther. 2001. PMID: 11498762

4

Perfusion and ventilation isotope lung scans in constrictive bronchiolitis obliterans. A series of three cases.

Hasegawa Y, Imaizumi K, Sekido Y, Iinuma Y, Kawabe T, Hashimoto N, Shimokata K. Hasegawa Y, et al. Among authors: hashimoto n. Respiration. 2002;69(6):550-5. doi: 10.1159/000066464. Respiration. 2002. PMID: 12457011

5

CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury.

Hashimoto N, Kawabe T, Imaizumi K, Hara T, Okamoto M, Kojima K, Shimokata K, Hasegawa Y. Hashimoto N, et al. Am J Respir Cell Mol Biol. 2004 Jun;30(6):808-15. doi: 10.1165/rcmb.2003-0197OC. Epub 2003 Dec 23. Am J Respir Cell Mol Biol. 2004. PMID: 14693668

6

Evaluation of interferon-gamma, interferon-gamma-inducing cytokines, and interferon-gamma-inducible chemokines in tuberculous pleural effusions.

Okamoto M, Kawabe T, Iwasaki Y, Hara T, Hashimoto N, Imaizumi K, Hasegawa Y, Shimokata K. Okamoto M, et al. Among authors: hashimoto n. J Lab Clin Med. 2005 Feb;145(2):88-93. doi: 10.1016/j.lab.2004.11.013. J Lab Clin Med. 2005. PMID: 15746651

7

T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.

Okamoto M, Hasegawa Y, Hara T, Hashimoto N, Imaizumi K, Shimokata K, Kawabe T. Okamoto M, et al. Among authors: hashimoto n. Chest. 2005 Dec;128(6):4030-5. doi: 10.1378/chest.128.6.4030. Chest. 2005. PMID: 16354877

8

Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer.

Nakanishi T, Imaizumi K, Hasegawa Y, Kawabe T, Hashimoto N, Okamoto M, Shimokata K. Nakanishi T, et al. Among authors: hashimoto n. Cancer Immunol Immunother. 2006 Nov;55(11):1320-9. doi: 10.1007/s00262-006-0133-y. Epub 2006 Feb 2. Cancer Immunol Immunother. 2006. PMID: 16453150 Free PMC article.

9

Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis.

Imaizumi K, Sugishita M, Usui M, Kawabe T, Hashimoto N, Hasegawa Y. Imaizumi K, et al. Among authors: hashimoto n. Intern Med. 2006;45(10):685-8. doi: 10.2169/internalmedicine.45.1623. Epub 2006 Jun 15. Intern Med. 2006. PMID: 16778341 Free article.

10

Successful re-treatment with gefitinib for carcinomatous meningitis as disease recurrence of non-small-cell lung cancer.

Hashimoto N, Imaizumi K, Honda T, Kawabe T, Nagasaka T, Shimokata K, Hasegawa Y. Hashimoto N, et al. Lung Cancer. 2006 Sep;53(3):387-90. doi: 10.1016/j.lungcan.2006.05.016. Epub 2006 Jul 5. Lung Cancer. 2006. PMID: 16824645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,416 results

Search Page

Filters